Literature DB >> 19168385

Role of Pseudomonas aeruginosa type III effectors in disease.

Joanne Engel1, Priya Balachandran.   

Abstract

Pseudomonas aeruginosa uses a type III secretion system (T3SS) to directly inject four known effectors into host cells. ExoU is a potent cytotoxin with phospholipase A2 activity that causes rapid necrotic death in many cell types. The biological function of ExoY, an adenylate cyclase, remains incompletely defined. ExoS and ExoT are closely related bifunctional proteins with N-terminal GTPase activating protein (GAP) activity toward Rho family proteins and C-terminal ADP ribosylase (ADPRT) activity toward distinct and non-overlapping set of targets. While almost no strain encodes or secretes all four effectors, the commonly found combinations of ExoU/ExoT or ExoS/ExoT provides redundant and failsafe mechanisms to cause mucosal barrier injury, inhibit many arms of the innate immune response, and prevent wound repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19168385     DOI: 10.1016/j.mib.2008.12.007

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  129 in total

1.  Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa.

Authors:  Xiang Xu; Hong Zhang; Yuanlin Song; Susan V Lynch; Clifford A Lowell; Jeanine P Wiener-Kronish; George H Caughey
Journal:  J Leukoc Biol       Date:  2011-11-10       Impact factor: 4.962

Review 2.  Lipoic acid metabolism in microbial pathogens.

Authors:  Maroya D Spalding; Sean T Prigge
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

3.  Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia.

Authors:  Weihui Wu; Jin Huang; Biyan Duan; David C Traficante; Haeyeon Hong; Martina Risech; Stephen Lory; Gregory P Priebe
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

4.  Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.

Authors:  Daniel Aiello; John D Williams; Helena Majgier-Baranowska; Ishan Patel; Norton P Peet; Jin Huang; Stephen Lory; Terry L Bowlin; Donald T Moir
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

5.  Full virulence of Pseudomonas aeruginosa requires OprF.

Authors:  Laurène Fito-Boncompte; Annelise Chapalain; Emeline Bouffartigues; Hichem Chaker; Olivier Lesouhaitier; Gwendoline Gicquel; Alexis Bazire; Amar Madi; Nathalie Connil; Wilfried Véron; Laure Taupin; Bertrand Toussaint; Pierre Cornelis; Qing Wei; Koki Shioya; Eric Déziel; Marc G J Feuilloley; Nicole Orange; Alain Dufour; Sylvie Chevalier
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

6.  The importance of the Pseudomonas aeruginosa type III secretion system in epithelium traversal depends upon conditions of host susceptibility.

Authors:  Aaron B Sullivan; K P Connie Tam; Matteo M E Metruccio; David J Evans; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

7.  Identification of Vibrio cholerae type III secretion system effector proteins.

Authors:  Ashfaqul Alam; Kelly A Miller; Mudit Chaand; J Scott Butler; Michelle Dziejman
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

8.  Assessing Pseudomonas virulence using host cells.

Authors:  Iwona Bucior; Cindy Tran; Joanne Engel
Journal:  Methods Mol Biol       Date:  2014

9.  Proteolytic activity of Pseudomonas aeruginosa isolates with TTSS-mediated cytotoxicity and invasiveness to host cells.

Authors:  Małgorzata A Stepińska; Ewa Ołdak; Elzbieta A Trafny
Journal:  Curr Microbiol       Date:  2009-12-03       Impact factor: 2.188

Review 10.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.